Bluebird Historical Income Statement
| BLUE Stock | USD 0.39 0.03 7.14% |
Historical analysis of Bluebird Bio income statement accounts such as Interest Expense of 31.6 M, Selling General Administrative of 126.8 M or Total Revenue of 41.4 M can show how well Bluebird bio performed in making a profits. Evaluating Bluebird Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bluebird Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bluebird bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bluebird bio is a good buy for the upcoming year.
Bluebird |
About Bluebird Income Statement Analysis
Bluebird bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bluebird Bio shareholders. The income statement also shows Bluebird investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bluebird Bio Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Bluebird bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bluebird bio. It is also known as Bluebird Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Bluebird Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 41.4 M, whereas Gross Profit is projected to grow to (3.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 529.9M | 275.7M | 273.8M | 373.9M | Cost Of Revenue | 38.9M | 10.1M | 33.5M | 36.1M |
Bluebird Bio income statement Correlations
Click cells to compare fundamentals
Bluebird Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bluebird Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 17.4M | 5.6M | 5.5M | 5.0M | 5.8M | 8.0M | |
| Interest Expense | 34.8M | 37.3M | 260.2M | 6.3M | 16.4M | 31.6M | |
| Selling General Administrative | 271.4M | 286.9M | 210.0M | 136.9M | 165.5M | 126.8M | |
| Total Revenue | 44.7M | 250.7M | 3.7M | 3.6M | 29.5M | 41.4M | |
| Gross Profit | 41.7M | 245.3M | (35.2M) | (6.5M) | (4.0M) | (3.8M) | |
| Other Operating Expenses | 856.8M | 880.2M | 568.8M | 285.7M | 328.6M | 385.4M | |
| Operating Income | (812.1M) | (629.5M) | (590.9M) | (287.1M) | (244.3M) | (256.5M) | |
| Ebit | (826.8M) | (559.3M) | (562.4M) | (220.6M) | (198.5M) | (208.4M) | |
| Research Development | 582.4M | 588.0M | 319.9M | 240.8M | 167.7M | 260.7M | |
| Ebitda | (809.3M) | (553.6M) | (556.9M) | (215.6M) | (194.0M) | (203.7M) | |
| Cost Of Revenue | 3.0M | 5.4M | 38.9M | 10.1M | 33.5M | 36.1M | |
| Total Operating Expenses | 853.8M | 874.9M | 529.9M | 275.7M | 273.8M | 373.9M | |
| Income Before Tax | (790.2M) | (618.0M) | (562.4M) | (266.5M) | (212.0M) | (222.6M) | |
| Total Other Income Expense Net | 21.9M | (1.1M) | 28.5M | 20.0M | 38.7M | 40.6M | |
| Net Income | (789.6M) | (618.7M) | (562.6M) | (266.6M) | (211.9M) | (222.5M) | |
| Income Tax Expense | (545K) | 686K | 258K | 117K | 134.6K | 141.3K | |
| Net Income From Continuing Ops | (789.6M) | (618.7M) | (562.6M) | (266.6M) | (211.9M) | (222.5M) | |
| Non Operating Income Net Other | 2.0M | (10.1M) | (6.5M) | 27.7M | 31.8M | 33.4M | |
| Net Income Applicable To Common Shares | (789.6M) | (618.7M) | (819.4M) | (266.6M) | (239.9M) | (251.9M) | |
| Tax Provision | (545K) | 686K | 258K | 117K | (126K) | (119.7K) | |
| Interest Income | 34.8M | 11.5M | 879K | 1.0M | 9.9M | 7.6M | |
| Net Interest Income | 34.8M | 11.5M | 879K | 1.0M | (6.5M) | (6.2M) | |
| Reconciled Depreciation | 17.4M | 19.4M | 19.6M | 5.0M | 28.5M | 19.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 0.357 | Quarterly Revenue Growth 1.337 | Return On Assets (0.36) | Return On Equity (1.87) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.